EHL BIO operates its cell-manufacturing centre to GMP principles: controlled facilities, trained personnel, written procedures and release testing such as cell count, viability and contamination checks. The centre can produce around 6,000 lots a year, each with traceable documentation. This is the foundation behind the trust of more than 100 partner hospitals in Korea and over 50 overseas.
Source: EHL BIO — GMP center
More in Technology & quality
Experts behind this content
EHL Thailand Medical Information Team — Evidence levels, regulatory status, and separating hospital information from medical information
EHL BIO scientific information is compiled alongside public information from its research team and GMP centre. See the full expert panel

